Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Acta Endocrinologica

• Publication date

  1983-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/ACTA.0.1020205PMID 6829260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of vasopressin on human memory functions.

  1981cited by this paper
• Desmopressin in post-traumatic amnesia.

  1979cited by this paper
• Influence of vasopressin on learning and memory.

  1978cited by this paper
• Neurohypophyseal principles and memory processes.

  1978cited by this paper
• Vasopressin and memory in Korsakoff syndrome.

  1978cited by this paper
• Vasopressin in amnesia.

  1978cited by this paper
• Vasopressin in amnesia.

  1978cited by this paper
• Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments.

  1976cited by this paper
• Intraventricular administration of anti-vasopressin serum inhibits.

  1975cited by this paper
• Memory deficit in rats with hereditary diabetes insipidus.

  1975cited by this paper
• Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion

  1972cited by this paper
• Long Term Effect of Vasopressin on the Maintenance of a Conditioned Avoidance Response in Rats

  1971cited by this paper

• The vasopressin−memory hypothesis: a citation network analysis of a debate

  2019cites this paper
• Association between the arginine vasopressin receptor 1A (AVPR1A) gene and preschoolers' executive functioning.

  2014cites this paper
• Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin.

  2009cites this paper
• Hypothalamic neuropeptides and memory

  2005cites this paper
• Neuropsychological effects of vasopressin in healthy humans.

  1998cites this paper
• Verbal memory after three months of intranasal vasopressin in healthy old humans.

  1997cites this paper
• Effect of acute and chronic treatment with desglycinamide-[Arg8]vasopressin in young male and female volunteers.

  1995cites this paper
• Iontophoresis of a Model Peptide Across Human Skin in Vitro: Effects of Iontophoresis Protocol, pH, and Ionic Strength on Peptide Flux and Skin Impedance

  1994cites this paper
• Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder.

  1993cites this paper
• Desglycinamide‐(Arg8)‐vasopressin in five trials with memory‐disturbed patients

  1992cites this paper
• Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects.

  1992cites this paper
• Effects of vasopressin on the habituation of the orienting reaction in men.

  1991cites this paper
• Vasopressin(1-8) (des-glycinamide9-[Arg8]vasopressin) is an endogenous peptide present in rat plasma.

  1991cites this paper
• Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research.

  1991cites this paper
• Influence of desglycinamide-(arg8) vasopressin on memory in healthy subjects.

  1990cites this paper
• The Effects of Vasopressin on Memory in Healthy Young Adult Volunteers

  1990cites this paper
• Behavioral effects of vasopressin

  1990cites this paper
• Dose-dependent effects of DDAVP on memory in healthy young adult males: a preliminary study.

  1990cites this paper
• Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.

  1989cites this paper
• The influence of a vasopressin-analogue (DGAVP) on event-related potentials in a stimulus-mismatch paradigm.

  1989cites this paper
• Effects of neurohypophyseal hormones on food-reinforced classical conditioning in the rat.

  1988cites this paper
• Effects of DGAVP on verbal memory.

  1988cites this paper
• Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men.

  1988cites this paper
• Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat.

  1988cites this paper
• Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice.

  1988cites this paper
• Vasopressin and memory: improvement in normal short-term recall and reduction of alcohol-induced amnesia

  1987cites this paper
• Vasopressin and human behaviour

  1987cites this paper
• Neuropeptides and Memory

  1987cites this paper
• Chapter 6 – Central Nervous System Effects of Neurohypophyseal Peptides*

  1987cites this paper
• Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients.

  1987cites this paper
• Animal and clinical studies of vasopressin effects on learning and memory.

  1987cites this paper
• Possible therapeutic implications of the effects of some peptides on the brain.

  1987cites this paper
• Pharmacological treatments of dementia (non-cholinergic).

  1986cites this paper
• Comparison of the effects of microinjections of angiotensin II and bradykinin into the lateral ventricles and their instillation into the conjunctiva on feeding behavior of rats

  1986cites this paper
• Neuropeptides and cognitive disorders.

  1986cites this paper
• Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.

  1986cites this paper
• [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate.

  1986cites this paper
• Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin

  1986cites this paper
• Vasopressin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory.

  1986cites this paper
• CHAPTER 7 – Structure–Activity of the Neurohypophyseal Hormones and Analogs and Implications for Hormone–Receptor Interactions

  1986cites this paper
• A mnemonic role for vasopressin: the evidence for and against.

  1985cites this paper
• Neuropeptides in Human Memory and Learning Processes

  1985cites this paper
• Immunocytochemical localization of vasopressin-binding sites in the rat kidney.

  1985cites this paper
• No improvement in ethanol-induced memory deficits after administration of a vasopressin analog.

  1985cites this paper
• A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man.

  1985cites this paper
• Vasopressin and related peptides: animal and human studies.

  1985cites this paper
• Vasopressin does not enhance memory processes: a study in human twins.

  1985cites this paper
• Oxytocin and Vasopressin in Memory and Amnesia

  1985cites this paper
• Vasopressin: site of behavioral action and role in human mental performance.

  1985cites this paper
• Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin.

  1984cites this paper
• Chapter 4. Cognitive Disorders

  1984cites this paper
• Vasopressin and memory.

  1983cites this paper
• Lack of effect of desglycinamide-arginine-vasopressin (DGAVP) on memory in patients with korsakoff's syndrome.

  1983cites this paper
• Vasopressin-like peptides and the treatment of memory disorders in man.

  1983cites this paper